The Benefits and Risks of Oral Antiplatelet Therapy in Patients with Acute Coronary Syndrome

Tariq Ahmad; Rhian Davies; Peter Alagona

The Benefits and Risks of Oral Antiplatelet Therapy in Patients with Acute Coronary Syndrome

Tariq Ahmad
, Rhian Davies
, Peter Alagona

Department of Medicine

Research output: Contribution to journal › Review article › peer-review

Abstract

This newsletter aims to provide an overview of the currently available evidence pertaining to the benefits and risks of oral antiplatelet therapies, with a focus on balancing ischemic and bleeding risk to optimize patient outcomes.

Original language	English (US)
Journal	The Journal of family practice
Volume	66
Issue number	2
State	Published - Feb 1 2017

All Science Journal Classification (ASJC) codes

General Medicine

Cite this

@article{a63faadefbf345b18a392c8a2c87e253,

title = "The Benefits and Risks of Oral Antiplatelet Therapy in Patients with Acute Coronary Syndrome",

abstract = "This newsletter aims to provide an overview of the currently available evidence pertaining to the benefits and risks of oral antiplatelet therapies, with a focus on balancing ischemic and bleeding risk to optimize patient outcomes.",

author = "Tariq Ahmad and Rhian Davies and Peter Alagona",

year = "2017",

month = feb,

day = "1",

language = "English (US)",

volume = "66",

journal = "The Journal of family practice",

issn = "0094-3509",

publisher = "Frontline Medical Communications Inc.",

number = "2",

}

TY - JOUR

T1 - The Benefits and Risks of Oral Antiplatelet Therapy in Patients with Acute Coronary Syndrome

AU - Ahmad, Tariq

AU - Davies, Rhian

AU - Alagona, Peter

PY - 2017/2/1

Y1 - 2017/2/1

N2 - This newsletter aims to provide an overview of the currently available evidence pertaining to the benefits and risks of oral antiplatelet therapies, with a focus on balancing ischemic and bleeding risk to optimize patient outcomes.

AB - This newsletter aims to provide an overview of the currently available evidence pertaining to the benefits and risks of oral antiplatelet therapies, with a focus on balancing ischemic and bleeding risk to optimize patient outcomes.

UR - https://www.scopus.com/pages/publications/85037691562

UR - https://www.scopus.com/pages/publications/85037691562#tab=citedBy

M3 - Review article

C2 - 29095443

AN - SCOPUS:85037691562

SN - 0094-3509

VL - 66

JO - The Journal of family practice

JF - The Journal of family practice

IS - 2

ER -

The Benefits and Risks of Oral Antiplatelet Therapy in Patients with Acute Coronary Syndrome

Abstract

All Science Journal Classification (ASJC) codes

Other files and links

Fingerprint

Cite this